Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Exscientia Ltd ADR
0RKCurrent price
4.16 EUR
-0.1 EUR (-2.35%)
Last closed
4.88 USD
Company
www.exscientia.ai
ISIN
US30223G1022
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
706 220 096 USD
Yield for 12 month
-10.91 %
1Y
3Y
5Y
10Y
15Y
0RK
Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy. It is also involved in the development of EXS4318, a PKC-theta inhibitor, under Phase 1 clinical trial for inflammation and immunology indications; EXS74539, a LSD1 inhibitor, under preclinical studies for SCLC, AML, and potential additional indications; EXS73565, a MALT1 inhibitor, under preclinical studies for multiple hematology indications; and DSP-0038, currently in Phase 1 studies. The company has collaboration agreements with Merck KGaA, Bristol Myers Squibb, Sanofi, Bill & Melinda Gates Foundation, Charité " Universitätsmedizin Berlin, Rallybio, and GT Apeiron Therapeutics. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom. Address: The Schrödinger Building, Oxford, United Kingdom, OX4 4GE
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
+32 790 018 USD
Last Year
+43 222 138 USD
Current Quarter
+5 805 429 USD
Last Quarter
+6 949 699 USD
Current Year
-37 421 350 USD
Last Year
-9 590 322 USD
Current Quarter
-4 387 901 USD
Last Quarter
-2 781 194 USD
Key Figures 0RK
1 year
3 years
5 years
10 years
EBITDA
-136 952 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.86 %
PEG Ratio
–
Return On Equity TTM
-36.34 %
Wall Street Target Price
6 USD
Revenue TTM
21 021 000 USD
Book Value
2.33 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
47 %
Dividend Yield
–
Gross Profit TTM
10 247 000 USD
Earnings per share
-1.36 USD
Diluted Eps TTM
-1.36 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0RK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0RK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 0RK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
12.609
Price Sales TTM
33.5959
Enterprise Value EBITDA
-1.6591
Price Book MRQ
1.8083
Financials 0RK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0RK
For 52 weeks
3.8 USD
7.91 USD
50 Day MA
5.32 USD
Shares Short Prior Month
3 189 839
200 Day MA
5.6 USD
Short Ratio
5.57
Shares Short
3 691 505
Short Percent
6 %
BeatStart